All sponsors

Chengdu Suncadia Medicine Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-19
ACTIVE TRIALS5
PHASE 3 / 2-31
RECRUITING1
READOUTS ≤12 MONTHS2
Open Chengdu Suncadia Medicine Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
HRS-3095 Tablet
NCT07613866
P2Not yet recruitingChronic Spontaneous Urticaria1902026-12
HRS-5965
NCT07014826
P3Active, not recruitingPrimary IgA Nephropathy3892027-10
HRS-5965 tablets
NCT06238544
P2Active, not recruitingParoxysmal Nocturnal Hemoglobinuria1322027-12
HRS-5965 Capsules
NCT07582133
P2RecruitingPrimary IgA Nephropathy3802029-07
HRS-9308 Tablet
NCT07940439
P1/2Not yet recruitingSolid Tumor1262030-12